On April 5, 2023 Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, reported that management will present at the 22nd Annual Needham Virtual Healthcare Conference being held April 17-20, 2023 (Press release, Sapience Therapeutics, APR 5, 2023, View Source [SID1234629847]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Sapience CEO and President, Dr. Barry Kappel, will present a company overview on Monday, April 17, 2023, at 11:00 am ET. Company management will also participate in virtual one-on-one meetings with investors during the conference.